pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,779 catalysts · 4,779 phase readout · 2,339 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: device pma×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings286
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›ENROLLING_BY_INVITATIONphase readoutNCT07405346: A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy

    Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: NA. Conditions: Advanced Leiomyosarcoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02782546: Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

    Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Acute Myeloid Leukemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04870788: Mindfulness-Based Intervention for Latino Cancer Patients and Their Caregivers

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Advanced Malignant Solid Neoplasm

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07548788: A Lay Navigation Intervention for Patients With Lung Cancer

    Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Lung Cancer Non-Small Cell Cancer (NSCLC), Lung Cancer Small Cell Lung Cancer (SCLC), Patient Navigation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07657403: CONNEctome-guided Navigation for Eloquent-area Tumor Surgery Trial

    Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: NA. Conditions: Brain Neoplasms, Eloquent Area Brain Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02689427: Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Triple-Negative Breast Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07493642: Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease

    Sponsor: Fu Jen Catholic University Hospital. Phase: NA. Conditions: Chronic Kidney Disease (CKD), CKD Stage 1-3

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04953273: A Case Management Algorithm for Women Victims of Violence

    Sponsor: University Hospital, Lille. Phase: NA. Conditions: Post-Traumatic Stress Disorder, Violence-Related Symptom

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07661173: A Prospective Study of Firmonertinib as First-line Adaptive Therapy Guided by Dynamic ctDNA (MRD) Changes in Locally Advanced or Metastatic EGFR-mutated Non-small Cell Lung Cancer

    Sponsor: Anhui Provincial Cancer Hospital. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05503069: Community Interventions to Improve Breastfeeding

    Sponsor: University of Mississippi Medical Center. Phase: NA. Conditions: Breastfeeding, Breastfeeding, Exclusive

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03407469: Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

    Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Cancer-related Venous Thromboembolism

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07360483: Treatment of Hypertrophic Scars Using Fractional CO2 Laser Alone in Comparison With Adding Botulinum Toxin Either Through Intralesional Injection or Assisted Drug Delivery

    Sponsor: Cairo University. Phase: NA. Conditions: Hypertrophic Scars

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03229083: Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma

    Sponsor: University of Rochester. Phase: NA. Conditions: Advanced Renal Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06411054: The Efficacy of Acu-TENS as an Adjunct Analgesic During USG-MVA

    Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Pain, Acute

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05078905: Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: COVID-19, Vaccination, Healthy Volunteer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06456905: Automated Reinforcement Management Systems, Phase II

    Sponsor: Washington State University. Phase: NA. Conditions: Alcohol Use Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07444905: Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma

    Sponsor: Tongji Hospital. Phase: . Conditions: HCC - Hepatocellular Carcinoma, Machine Learning, Evaluation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07352605: Percutaneous Drainage Versus Antibiotic Therapy for Acute Diverticulitis With Abscess.

    Sponsor: Azienda Sanitaria di Firenze. Phase: NA. Conditions: Diverticular Disease of Colon

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07221266: Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs

    Sponsor: University of Texas, El Paso. Phase: NA. Conditions: Parkinson Disease (PD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00455156: Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring

    Sponsor: Premier Research. Phase: PHASE3. Conditions: Contraception

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07511166: A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized Sedation

    Sponsor: Johnson & Johnson Medical (Shanghai) Ltd.. Phase: . Conditions: Atrial Fibrillation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05287256: Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC

    Sponsor: Johns Hopkins University. Phase: PHASE1. Conditions: Behavioral Pharmacology of Cannabis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05678322: Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy

    Sponsor: NYU Langone Health. Phase: PHASE3. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07382622: Effect of JointIQ on Joint Discomfort in Healthy Subjects

    Sponsor: Chung Shan Medical University. Phase: NA. Conditions: Joint Discomfort

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07056322: Optimal Meals to Reduce Bone Resorption in Women With Osteopenia

    Sponsor: University of Aarhus. Phase: NA. Conditions: Osteopenia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07552220: Muscle Imaging Project Using ANatomopathology and Full Field Optical Coherence Tomography

    Sponsor: Centre Hospitalier de Mâcon. Phase: . Conditions: Myositis, Health Adult Subjects

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06635824: Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)

    Sponsor: Genmab. Phase: PHASE3. Conditions: PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06373380: A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: EARLY_PHASE1. Conditions: HPV16+ Squamous Cell Carcinoma

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT06364280: Pediatric Prehospital Airway Resuscitation Trial

    Sponsor: Ohio State University. Phase: NA. Conditions: Heart Arrest, Out-Of-Hospital, Wounds and Injuries, Respiratory Insufficiency in Children, Child, Only, Critical Illness

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07290296: Popliteus Muscle Release Versus Kinesio Taping

    Sponsor: Cairo University. Phase: NA. Conditions: Patellofemoral Pain Syndrome

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07612696: Impact of Electronic Cigarette Temperature and Solvent on Biomarkers

    Sponsor: Milton S. Hershey Medical Center. Phase: NA. Conditions: Oxidative Stress, Tobacco Use, Electronic Cigarettes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04406662: Routine Evaluation of People Living With Cancer

    Sponsor: University of Edinburgh. Phase: . Conditions: Cachexia; Cancer, Advanced Cancer, Quality of Life

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07639762: Comparison of the Efficacy of Ultrasound-guided Supra-inguinal Fascia Iliaca and Lumbar Erector Spina Plan Block in Hip Fractures

    Sponsor: Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital. Phase: . Conditions: Hip Fracture, Pain Management, Multimodal Analgesia, Peripheral Nerve Block, Lumbar Erector Spinae Plane Block, Suprainguinal Fasia Iliaca Block

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07108062: Using Tele-rehabilitation on Management of Pediatric Nocturnal Enuresis

    Sponsor: Hungarian University of Sports Science. Phase: NA. Conditions: Enuresis Nocturnal, Urinary Incontinence

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06295562: Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea

    Sponsor: China Medical University Hospital. Phase: PHASE4. Conditions: Obstructive Sleep Apnea of Adult

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07098962: KinesioTaping for Thoracic Drain Support

    Sponsor: Kastamonu University. Phase: PHASE2. Conditions: Primary Condition: Pain, Postoperative, Associated Conditions: Cardiac Surgical Procedures, Thoracic Surgery

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01783288: Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening

    Sponsor: Vanderbilt University. Phase: NA. Conditions: Postural Tachycardia Syndrome

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07644403: Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.

    Sponsor: Suzhou Immunofoco Biotechnology Co., Ltd. Phase: PHASE1. Conditions: Epithelial Cancer Patients

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07465627: Vessel Recoil in Specific CLTI Populations

    Sponsor: Medical University of Graz. Phase: . Conditions: Chronic Limb Threatening Ischemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06553027: To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

    Sponsor: Cerevance. Phase: PHASE3. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07541261: A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia

    Sponsor: Janssen Research & Development, LLC. Phase: . Conditions: Colitis, Ulcerative, Crohn Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06954961: A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer

    Sponsor: InventisBio Co., Ltd. Phase: PHASE3. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05617742: Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer

    Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Lung Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07316686: Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma

    Sponsor: Instituto do Cancer do Estado de São Paulo. Phase: PHASE1. Conditions: Prostate Cancer (Adenocarcinoma)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05176470: Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

    Sponsor: Richard Wu. Phase: PHASE1. Conditions: Locally Advanced Melanoma, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Stage IV Melanoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06285773: Recto-intercostal Fascial Plane Block and Pecto-intercostal Fascial Plane Block for Cardiac Surgery

    Sponsor: Medipol University. Phase: NA. Conditions: Cardiac Disease

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07298486: Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALS

    Sponsor: Nova Southeastern University. Phase: NA. Conditions: Amyotrophic Lateral Sclerosis (ALS)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07461870: The Mediterranean Diet Based on Local Foods for Obese Patients

    Sponsor: Indonesia University. Phase: NA. Conditions: Obese Subjects

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06714370: Real-World Evidence of Effectiveness and Safety of Tirabrutinib in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma in Taiwan: A Nationwide Study

    Sponsor: Ono Pharmaceutical Co., Ltd.. Phase: . Conditions: Primary Central Nervous System Lymphoma (PCNSL)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07602270: Effects of Ketogenic Diet on Alcohol Intoxication

    Sponsor: University of Pennsylvania. Phase: NA. Conditions: Ketogenic Diet, Alcohol Drinking, Alcohol Use Disorder, Magnetic Resonance Imaging, Alcohol Intoxication

    full page →ctgov ↗
    ← prev
    page 74 of 96
    next →